Proteovant Therapeutics
Helai has 15+ years of experience in oncology research with an emphasis on epigenetics. Previously Senior Scientific Director at GlaxoSmithKline.
This person is not in any offices
Proteovant Therapeutics
Proteovant Therapeutics is a biotechnology company that utilizes protein degradation research in the development of medicines for diseases.